169 related articles for article (PubMed ID: 11023533)
21. Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score.
Guan M; Chen Y
J Clin Pathol; 2005 Nov; 58(11):1175-9. PubMed ID: 16254107
[TBL] [Abstract][Full Text] [Related]
22. Orthotopic expression of human 15-lipoxygenase (LO)-1 in the dorsolateral prostate of normal wild-type C57BL/6 mouse causes PIN-like lesions.
Sen M; McHugh K; Hutzley J; Philips BJ; Dhir R; Parwani AV; Kelavkar UP
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):1-13. PubMed ID: 16997127
[TBL] [Abstract][Full Text] [Related]
23. Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines.
Spindler SA; Sarkar FH; Sakr WA; Blackburn ML; Bull AW; LaGattuta M; Reddy RG
Biochem Biophys Res Commun; 1997 Oct; 239(3):775-81. PubMed ID: 9367845
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
Tamboli P; Amin MB; Xu HJ; Linden MD
Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy.
Abaza R; Diaz LK; Laskin WB; Pins MR
J Urol; 2006 Dec; 176(6 Pt 1):2701-5. PubMed ID: 17085199
[TBL] [Abstract][Full Text] [Related]
26. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
27. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
[TBL] [Abstract][Full Text] [Related]
28. Diverse roles of 2-arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12-lipoxygenase metabolism.
Endsley MP; Aggarwal N; Isbell MA; Wheelock CE; Hammock BD; Falck JR; Campbell WB; Nithipatikom K
Int J Cancer; 2007 Sep; 121(5):984-91. PubMed ID: 17443494
[TBL] [Abstract][Full Text] [Related]
29. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene.
Kelavkar UP; Badr KF
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4378-83. PubMed ID: 10200270
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
32. A molecular correlate to the Gleason grading system for prostate adenocarcinoma.
True L; Coleman I; Hawley S; Huang CY; Gifford D; Coleman R; Beer TM; Gelmann E; Datta M; Mostaghel E; Knudsen B; Lange P; Vessella R; Lin D; Hood L; Nelson PS
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10991-6. PubMed ID: 16829574
[TBL] [Abstract][Full Text] [Related]
33. Expression of Peroxisome Proliferator Activated Receptor gamma in Prostatic Adenocarcinoma.
Park HK; Kim H; Kim HG; Cho YM; Jung WY; Han HS; Hwang TS; Kwon GY; Lim SD
J Korean Med Sci; 2015 May; 30(5):533-41. PubMed ID: 25931782
[TBL] [Abstract][Full Text] [Related]
34. Attenuated response of p53 and p21 in primary cultures of human prostatic epithelial cells exposed to DNA-damaging agents.
Girinsky T; Koumenis C; Graeber TG; Peehl DM; Giaccia AJ
Cancer Res; 1995 Sep; 55(17):3726-31. PubMed ID: 7543816
[TBL] [Abstract][Full Text] [Related]
35. Relationship between apoptosis regulator proteins (bcl-2 and p53) and Gleason score in prostate cancer.
Karaburun Paker S; Kilicarslan B; Ciftcioglu AM; Oztekin S; Sargin FC; Erdogru T; Baykara M
Pathol Oncol Res; 2001; 7(3):209-12. PubMed ID: 11692148
[TBL] [Abstract][Full Text] [Related]
36. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer.
Gao X; Grignon DJ; Chbihi T; Zacharek A; Chen YQ; Sakr W; Porter AT; Crissman JD; Pontes JE; Powell IJ
Urology; 1995 Aug; 46(2):227-37. PubMed ID: 7624992
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical determination of p53 protein in prostatic cancer and prostatic intraepithelial neoplasms.
Yaman O; Ozdiler E; Orhan D; Sak SD; Baltaci S; Tulunay O; Göğüş O
Urol Int; 1997; 58(4):199-202. PubMed ID: 9253117
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the activity and localization of 15-lipoxygenase-1 after introduction into human colorectal carcinoma Caco-2 cells.
Hsi LC; Kamitani H; Cornicelli JA; Eling TE
Prostaglandins Leukot Essent Fatty Acids; 2001; 64(4-5):217-25. PubMed ID: 11418015
[TBL] [Abstract][Full Text] [Related]
39. Lipofuscin pigment can be used as a prognostic marker in prostatic adenocarcinoma.
Mahmoodi M; Zhang S; Salim S; Hou JS; Garcia FU
Ann Diagn Pathol; 2006 Oct; 10(5):257-62. PubMed ID: 16979516
[TBL] [Abstract][Full Text] [Related]
40. Cytosolic overexpression of p62 sequestosome 1 in neoplastic prostate tissue.
Kitamura H; Torigoe T; Asanuma H; Hisasue SI; Suzuki K; Tsukamoto T; Satoh M; Sato N
Histopathology; 2006 Jan; 48(2):157-61. PubMed ID: 16405664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
